In Scientific Session II we had interesting talks about #NRF2 and Inflammation from A. Klar, R. Foresti, S. Cuevas, B. Buttari and A. I. Rojo Sanchís @NRF2LabIIB
Today we started with Scientific Session I: New therapeutic approaches involving #NRF2 with A.T. Dinkova-Kostova, A. Grochot-Przeczek, M. Seabra, I. Varela @IIBmCSICUAM D. Miljkovic, A. Čipak Gašparović and V. Marisa Costa
We are delighted to welcome Julia Eckl-Dorna from the Upper Airway Research Lab at the Medical University of Vienna as our next #ScientistintheSpotlight!
Register now:
https://t.co/kyWVvJm2Qo
#CyTOF#cytometry#sinusitis
🧬 Biologics: Are they a threat or a valuable asset to the ENT community?
For further insights, EUFOREA has welcomed Dr Sven Schneider, from Austria, @ViennaAirwayLab & @DrStellaLee, from the USA! #biologics
Watch here: https://t.co/8k89GF4qQx
Our recent work has just been published on #medRxiv: Dupilumab dampens mucosal type 2 response during acetylsalicylic acid challenge in N-ERD patients https://t.co/dWjem1hO2U
Check out the latest publication by members of the #BenBedPhar#COSTaction#CA20121 on a consensus panel of markers for NRF2 signalling activity across different cell types and tissues.
Biomarkers of NRF2 signalling: Current status and future challenges https://t.co/ye9wLwtjfJ
New publication within our COST action @benbedphar on the role of thiosulfate sulfurtransferase in the brain and the involvement of #NRF2: Don't miss it 👇🏼
https://t.co/Ws3wl8LpFm
Interested in academic teaching careers? Join our panel of speakers for the next EMBL Careers Webinar on 26 November to learn more.
Open and free to all, registration required: https://t.co/CQTiLpxklp